In this context, upregulation of VCAM-1 and integrin α4 expression in tumor-associated LECs, due to the presence of tumor-derived inflammatory factors, leads to weakened LEC junctions, further contributing to increased lymphatic permeability and cancer cell penetration into LVs (157) (Figure 4A). The gene discussed is VCAM1; the disease is neoplasm.